Canadian trademark law

Minister of Justice and Attorney General of Canada announces a judicial appointment to the Federal Court

Retrieved on: 
Monday, February 20, 2023
IPIC, Government of Canada, Justice, Life, Woman, Government, Canadian trademark law, Disability, Intellectual Property Institute, LLP, Smart, Assistant, Legislation, Bachelor of Laws, Intellectual property, McGill University, Lawyer, Dignity, Language, Tax Court of Canada, Face, Federal Court of Canada, Criminal code, Questionnaire, Federal court, Judiciary Act of 1925, Survivor, The Honourable, Associate, The Criminal Code, Tax court, Cabinet, Canadian Intellectual Property Office, Trademarks Act, 2004, Principal, Superior court, Pharmaceutical industry, Physiology, Science, IP

OTTAWA, ON, Feb. 20, 2023 /CNW/ - The Honourable David Lametti, Minister of Justice and Attorney General of Canada, today announced the following appointment under the judicial application process established in 2016.

Key Points: 
  • OTTAWA, ON, Feb. 20, 2023 /CNW/ - The Honourable David Lametti, Minister of Justice and Attorney General of Canada, today announced the following appointment under the judicial application process established in 2016.
  • I am confident she will serve Canadians well as a member of the Federal Court."
  • Budget 2022 provides for 22 new judicial positions, along with two associate judges at the Tax Court of Canada.
  • Federal judicial appointments are made by the Governor General, acting on the advice of the federal Cabinet and recommendations from the Minister of Justice.

transcosmos's affiliated company UNQ, a leading Chinese e-commerce solutions provider launches IPO in HKEX main board

Retrieved on: 
Friday, July 16, 2021
Trademark law, Intellectual property law, Brand management, Product management, Marketing, Intangible assets, Trademark, Registered trademark symbol, Canadian trademark law

*transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.

Key Points: 
  • *transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.
  • *Other company names and product or service names used here are trademarks or registered trademarks of respective companies.
  • *Other company names and product or service names used here are trademarks or registered trademarks of respective companies.
  • *This press release is for information purposes only and should not be construed as investment advice or an offer or solicitation to buy or sell securities.

NLS Pharmaceutics Ltd. Announces Notice of Allowance of a New Technology Patent Covering Attention Deficit Hyperactivity Disorder & Narcolepsy

Retrieved on: 
Thursday, January 21, 2021
Intellectual property law, Psychoactive drugs, Canadian patent law, Canadian intellectual property law, Childhood psychiatric disorders, Psychiatric diagnosis, Canadian Intellectual Property Office, Canadian trademark law, Attention deficit hyperactivity disorder, CIPO, Attention deficit, Mazindol

On November 23, 2020, the Canadian Intellectual Property Office (CIPO) issued a similar notice of allowance for the counterpart Canadian application.

Key Points: 
  • On November 23, 2020, the Canadian Intellectual Property Office (CIPO) issued a similar notice of allowance for the counterpart Canadian application.
  • NLS awaits the impending grant of the European and Canadian patents.
  • 17724102, entitled "A MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)", has been examined and allowed for issuance as a patent by the EPO on January 21, 2021.
  • This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws.

Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions

Retrieved on: 
Tuesday, January 12, 2021
Intellectual property law, European Patent Organisation, Canadian Intellectual Property Office, Canadian intellectual property law, Canadian trademark law, Trademarks Opposition Board, Opposition procedure before the European Patent Office, Opposition proceeding

The new hearing date is set for September 6, 2021.

Key Points: 
  • The new hearing date is set for September 6, 2021.
  • On January 29, 2018, the Opposition Division of the EPO concluded the oral proceedings concerning the 355 Patent (the Opposition Proceeding).
  • Management expects the TBA to issue a ruling on the same day as the hearing, with a fully reasoned decision approximately two months following the hearing.
  • The denial of a request to rehear would end the Opposition Proceeding in favor of the opponents.